Money

Ozempic hit – a whopping $80 billion market by 2030

Published

2 years ago

January 5, 2024

The global market for obesity drugs is set to skyrocket, potentially reaching a staggering $80 billion by 2030.

This meteoric rise comes on the heels of increasing health concerns and a growing desire for a healthier lifestyle worldwide.

Experts are now asking, can these obesity drugs truly deliver on their promises, or are they just another quick-fix solution? With such a massive market at stake, it’s a question that’s got everyone talking.

As the obesity epidemic continues to grip nations, pharmaceutical companies are racing to develop and market drugs that can help individuals shed excess weight.

This aggressive push has ignited fierce competition, with innovative solutions emerging from unexpected sources.

But with the allure of quick weight loss, are there hidden dangers lurking beneath the surface? Are these drugs truly safe, or could they have unforeseen consequences on our health? As the industry booms, regulatory bodies face mounting challenges to ensure the safety and efficacy of these medications.

The implications of this $80 billion market extend far beyond the pharmaceutical industry. How will this burgeoning industry impact healthcare systems globally? Can society manage the potential side effects, both medically and economically?

Money

Australia’s inflation report and Nvidia earnings impact explained

Australia’s inflation report sparks market shifts, influencing interest rates, the Aussie dollar, and investor sentiment amid Nvidia’s earnings.

Published

4 days ago

February 26, 2026

Harvey Vargas

Australia’s inflation report sparks market shifts, influencing interest rates, the Aussie dollar, and investor sentiment amid Nvidia’s earnings.

Australia’s latest inflation report is creating waves across the market, with questions about interest rates, the strong performance of the Aussie dollar, and the uneven nature of the stock market rally. Investors are watching closely as changes in carry trade risks this month add another layer of complexity.

David Scutt from StoneX discusses what these shifts mean for trading strategies and the broader economic outlook. He provides insight into how underlying factors are shaping investor confidence and market dynamics.

On the tech side, Nvidia’s upcoming earnings are expected to influence AI development and the broader tech sector. Coupled with trends in SaaS and bitcoin price action, these movements are signalling how investor sentiment is evolving in a fast-changing landscape.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker

#AustraliaEconomy #InflationReport #AussieDollar #NvidiaEarnings #AIInvesting #StockMarketNews #BitcoinTrends #SaaSInsights

Money

U.S. stocks rally as AMD, Home Depot, and AI software lead gains

U.S. equities rose as AI disruption fears eased, with Home Depot, AMD, and DocuSign driving tech stock gains.

Published

5 days ago

February 25, 2026

Harvey Vargas

U.S. equities rose as AI disruption fears eased, with Home Depot, AMD, and DocuSign driving tech stock gains.

U.S. tech stocks surged as investors’ fears over AI disruption eased. Advanced Micro Devices jumped 9% after Meta announced a multiyear deal to deploy AMD’s graphics processing units for AI data centres. The move highlights growing corporate confidence in AI infrastructure investments.

DocuSign also rose 3% following Anthropic’s confirmation that Claude Cowork can integrate with DocuSign, Google Drive, and Gmail, signalling stronger adoption of AI tools across industries.

The iShares Expanded Tech-Software Sector ETF climbed 2% despite remaining over 30% below its 52-week high, showing tech stocks are recovering but still have room to run.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker

Money

Stocks tumble amid AI concerns and Trump tariff update

Dow drops 800+ points as AI and trade worries hit tech and retail stocks; bonds rise amid market volatility.

Published

6 days ago

February 24, 2026

Harvey Vargas

Dow drops 800+ points as AI and trade worries hit tech and retail stocks; bonds rise amid market volatility.

Stocks plunged sharply as concerns over artificial intelligence and trade tensions rattled investors, sending the Dow down more than 800 points. Heavyweights like American Express, Goldman Sachs, and JPMorgan were key contributors to the drop.

Software companies were hit particularly hard after a report suggested AI could impact economic growth, triggering further losses across tech shares.

Trade-sensitive retailers including American Eagle Outfitters, Ralph Lauren, and Yeti Holdings also faced setbacks as market uncertainty spiked. Bonds, meanwhile, rallied as investors sought safety in a volatile market.

Subscribe to never miss an episode of Ticker – https://www.youtube.com/@weareticker